他们展示了一种可以当做“生物标记物”特殊的蛋白，鉴别出使用新型肿瘤药物有效的稀有类型非霍奇金淋巴瘤的病人。
They show that a specific protein can be used as a 'biomarker' to identify which patients with a rare type of non-Hodgkin lymphoma would benefit from a new class of cancer drug.
作为一种较特异的肿瘤标记物，Y抗原在乳腺癌的诊断和对肿瘤生物学行为的研究方面具有一定意义。
Y antigen, as a specific tumor-associated marker, may be used in diagnosis of breast cancer and in promotion of the study in biologic behaviour of cancer.
你可以想象在未来，从病人的肿瘤取出组织，经过上百个不同生物标记物的筛选。
'You can imagine in the future a biopsy will be taken of a patient's tumour and screened for the presence of a hundred different biomarkers.
应用推荐